SectorPharmaceutical
Established Date--
Listing Date10/10/2019
ExchangeNASDAQ Stock Exchange
Full-time Employees17
Fiscal Year Ends31/12
Security TypeCommon stock
Office address2222 Ponce de Leon Blvd., Floor 3, Coral Gables, FL 33134
Business
IntroductionRelmada Therapeutics, Inc., was incorporated under the laws of the State of Nevada. The company is a publicly traded clinical-stage biotechnology company that has shifted its strategic focus following a review of its development programs. It is advancing its R&D pipeline through licensing introductions and acquisitions, including a Phase 2 bladder cancer drug candidate and a neurosteroid for neurological and metabolic diseases ready to enter Phase 2 b.
